Follow
Vijay Kumar Prajapati
Vijay Kumar Prajapati
Associate Professor, Department of Biochemistry, University of Delhi South Campus
Verified email at south.du.ac.in
Title
Cited by
Cited by
Year
Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use
S Sundar, A Singh, M Rai, VK Prajapati, AK Singh, B Ostyn, M Boelaert, ...
Clinical infectious diseases 55 (4), 543-550, 2012
3332012
Exploring dengue genome to construct a multi-epitope based subunit vaccine by utilizing immunoinformatics approach to battle against dengue infection
M Ali, RK Pandey, N Khatoon, A Narula, A Mishra, VK Prajapati
Scientific reports 7 (1), 9232, 2017
3052017
Exploring Leishmania secretory proteins to design B and T cell multi-epitope subunit vaccine using immunoinformatics approach
N Khatoon, RK Pandey, VK Prajapati
Scientific reports 7 (1), 8285, 2017
2972017
Novel Immunoinformatics Approaches to Design Multi-epitope Subunit Vaccine for Malaria by Investigating Anopheles Salivary Protein
RK Pandey, TK Bhatt, VK Prajapati
Scientific reports 8 (1), 1125, 2018
2092018
Targeted killing of Leishmania donovani in vivo and in vitro with amphotericin B attached to functionalized carbon nanotubes
VK Prajapati, K Awasthi, S Gautam, TP Yadav, M Rai, ON Srivastava, ...
Journal of antimicrobial chemotherapy 66 (4), 874-879, 2011
1682011
Evolutionary genomics of epidemic visceral leishmaniasis in the Indian subcontinent
H Imamura, T Downing, F Van den Broeck, MJ Sanders, S Rijal, S Sundar, ...
Elife 5, e12613, 2016
1602016
Drug susceptibility in Leishmania isolates following miltefosine treatment in cases of visceral leishmaniasis and post kala-azar dermal leishmaniasis
V Bhandari, A Kulshrestha, DK Deep, O Stark, VK Prajapati, V Ramesh, ...
PLoS neglected tropical diseases 6 (5), e1657, 2012
1212012
Molecular and immunological toxic effects of nanoparticles
RK Pandey, VK Prajapati
International journal of biological macromolecules 107, 1278-1293, 2018
1122018
Circulating MicroRNAs: potential and emerging biomarkers for diagnosis of human infectious diseases
P Verma, RK Pandey, P Prajapati, VK Prajapati
Frontiers in microbiology 7, 190570, 2016
1112016
Immunoinformatics approaches to design a novel multi-epitope subunit vaccine against HIV infection
RK Pandey, R Ojha, VS Aathmanathan, M Krishnan, VK Prajapati
Vaccine 36 (17), 2262-2272, 2018
1032018
Racial disparities in prostate cancer: a molecular perspective
A Bhardwaj, SK Srivastava, MA Khan, VK Prajapati, S Singh, JE Carter, ...
Frontiers in bioscience (Landmark edition) 22, 772, 2017
1012017
Antileishmanial activity of nano-amphotericin B deoxycholate
KD Manandhar, TP Yadav, VK Prajapati, S Kumar, M Rai, A Dube, ...
Journal of Antimicrobial Chemotherapy 62 (2), 376-380, 2008
962008
An oral formulation of amphotericin B attached to functionalized carbon nanotubes is an effective treatment for experimental visceral leishmaniasis
VK Prajapati, K Awasthi, TP Yadav, M Rai, ON Srivastava, S Sundar
Journal of Infectious Diseases 205 (2), 333-336, 2012
932012
Characterisation of antimony-resistant Leishmania donovani isolates: biochemical and biophysical studies and interaction with host cells
R Mukhopadhyay, S Mukherjee, B Mukherjee, K Naskar, D Mondal, ...
International journal for parasitology 41 (13-14), 1311-1321, 2011
912011
Designing B‐and T‐cell multi‐epitope based subunit vaccine using immunoinformatics approach to control Zika virus infection
R Kumar Pandey, R Ojha, A Mishra, V Kumar Prajapati
Journal of cellular biochemistry 119 (9), 7631-7642, 2018
902018
High throughput virtual screening reveals SARS-CoV-2 multi-target binding natural compounds to lead instant therapy for COVID-19 treatment
B Naik, N Gupta, R Ojha, S Singh, VK Prajapati, D Prusty
International Journal of Biological Macromolecules 160, 1-17, 2020
892020
Differential expression of miRNA regulates T cell differentiation and plasticity during visceral leishmaniasis infection
RK Pandey, S Sundar, VK Prajapati
Frontiers in microbiology 7, 186717, 2016
892016
Emerging role of circular RNAs as potential biomarkers for the diagnosis of human diseases
R Ojha, R Nandani, N Chatterjee, VK Prajapati
Circular RNAs: Biogenesis and Functions, 141-157, 2018
732018
Drug targeting to infectious diseases by nanoparticles surface functionalized with special biomolecules
S Sundar, V Kumar Prajapati
Current medicinal chemistry 19 (19), 3196-3202, 2012
732012
Unusual case of resistance to amphotericin B in visceral leishmaniasis in a region in India where leishmaniasis is not endemic
P Srivastava, VK Prajapati, M Rai, S Sundar
Journal of clinical microbiology 49 (8), 3088-3091, 2011
722011
The system can't perform the operation now. Try again later.
Articles 1–20